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Sensitivity, Specificity, Negative and Positive Predictive Values 
of Adenosine Deaminase in Patients of Tubercular and 
Non-Tubercular Serosal Effusion in India
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Abstract
Background: In India, tuberculosis is an endemic disease. Delay 
in diagnosis results in poor prognosis and fast spread of the disease. 
The objective of the present study is to look for an effective and 
acceptable diagnostic test, which may be helpful to initiate early 
treatment to improve prognosis and reduce spread.
Methods: Three hundred and thirty patients with pleural, ascitic, 
meningeal and synovial effusion were selected and divided depend-
ing upon the etiology and the involvement of serosal membranes. 
Serosal aspirated fluid was subjected to biochemical tests and ad-
enosine deaminase estimation. Cutoff taken is above 40 for pleural, 
peritoneal or synovial fluid and above 10 for CSF.
Results: In cases of pulmonary and extra-pulmonary disease, sen-
sitivity was 92.80% and 94.29%; specificity 90.00% and 92.16%; 
positive predictive value 92.86% and 89.00%; and negative predic-
tive value 90.00% and 95.92% respectively.
Conclusions: Adenosine deaminase estimation is not only a fairly 
sensitive and specific test (more than 90%), helpful in differentiat-
ing tubercular from non-tubercular etiology both in pulmonary and 
extra-pulmonary disease, but is also simple, inexpensive and rapid. 
For this reason this test may help in early diagnosis, improve the 
prognosis and reduce spread of disease and sequlae.
Keywords: Adenosine  deaminase;  Serosal  effusion; Tubercular; 
Non-tubercular; Pulmonary; Extra-pulmonary
Introduction
Tuberculosis is one of the commonest chronic infectious dis-
eases, which is highly endemic in India and five lakh patients 
die every year [1]. It usually affects lungs but cases of extra-
pulmonary tuberculosis are not rare. Delay in diagnosis and 
in initiating treatment results in poor prognosis and sequlae 
in up to 25% of cases [2]. In a large percentage of cases, 
involvement of pleura, peritoneum, meninges and synovial 
membranes is also common. Pulmonary Tuberculosis (TB) 
can be confirmed by sputum examination and diagnosed eas-
ily, but diagnosing extra-Pulmonary TB becomes frequently 
difficult since the specificity and sensitivity of non-invasive 
methods is very low. 
When aspirated serosal fluids were analyzed for direct 
evidence of disease, acid fast bacilli (AFB) positivity rate is 
very low and this process is time consuming also. AFB cul-
ture is expensive and requires long incubation period and is 
positive in less than 25% cases (Rafae Laniado-Laborin). Di-
rect examination of pleural fluid by Zeihl-Neelsen staining 
requires bacillary densities of 10,000/mL [3] and, therefore, 
detects AFB in less than 10% of cases. Elisa, PCR, Tub IgG 
and IgM, and interferon are very expensive tests and beyond 
the reach of the general population in poor countries.
Adenosine deaminase (ADA) is an enzyme in the purine 
salvage pathway that catalyzes the conversion of adenosine 
and deoxyadenosine to inosine and deoxyinosine with the 
release of ammonia. It plays important role in differentiat-
ing lymphoid cells and is present in abundance in active T-
lymphocytes whose concentration is inversely proportional 
to the degree of differentiation [4]. Its levels are ten times 
higher in T-lymphocytes than in erythrocytes. The enzyme 
activity increases during mitogenic and antigenic responses 
of lymphocytes, and T-lymphocyte blastogenesis can be in-
hibited by inhibitors of ADA. Likewise, a deficiency of ad-
enosine deaminase is associated with severe defects in the 
cell-mediated and humoral arms of the immune system, pre-
disposing the patient to opportunistic infections.
Tuberculous effusion is the result of a cell-mediated im-
mune response to the presence of Mycobacterium tuberculii 
and is characterized by the accumulation of activated T-lym-
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phocytes and macrophages. Elevated levels of ADA in tuber-
culous effusions have been noted by several authors. ADA 
is now being recognized as a marker of cell-mediated im-
munity particularly as a marker of T-lymphocyte activation.  
Since ADA is increased in TB effusions and is an easy 
little-invasive investigation, it is frequently considered as a 
diagnostic aid in such cases with a sensitivity of 90 - 100% 
and specificity 89-100%. ADA levels have also been con-
sidered by several researchers to differentiate tubercular dis-
ease from non-tubercular [5-7]. The aim of the present study 
is to: (1) propose a simple, rapid and cost effective test for 
diagnosing tuberculosis and differentiating it from other eti-
ologies both in pulmonary and extra-pulmonary disease with 
fairly good accuracy; (2) initiate early anti-tubercular treat-
ment to improve prognosis and reduce spread and sequlae. 
 
Methods
Patients attending out and in-patient departments of chest 
and respiratory diseases, medicine, pediatrics and orthope-
dic surgery of Subharti Medical College and its rural and 
urban health Centers at Sarawani, Mahalwala, Khajoori and 
Multan Nagar at distant places in district Meerut of India 
from January 2007 to October 2009 with pleural, peritoneal, 
meningeal and synovial tubercular disease with serosal effu-
sion were taken. 
The project was approved by the ethical committee of 
our institution. After taking informed consent, 330 such pa-
tients were included in the present study. Detailed clinical 
history, physical examination, investigations, for example, 
Hb, T/DLC, ESR, GBP, CBC, SGOT, SGPT, PPD test and 
X-ray/ultrasound were done in all the cases. AFB in the spu-
tum/fluid, AFB culture, ECG, cytology and biopsy with its 
histopathological examination were done in selective cases. 
Effusions were aspirated and fluid was subjected to the 
biochemical examination and ADA activity testing. Any oth-
er relevant/necessary/required investigations were also car-
ried out in specific case. 
Presence of first or more than one of the following cri-
teria was adopted to label a case as tuberculous: (1) Bacte-
riological confirmation of presence of Mycobacterium tuber-
culosis (direct smear or culture or histological finding); (2) 
Histopathology finding of caseous granulomas; (3) Radio-
logical findings consistent with TB; (4) Clinical presentation 
consistent with TB with exclusion of other clinical consider-
ations; (5) Definite clinical and radiological improvement in 
two months on administration of exclusive anti-tuberculosis 
treatment; (6) History of contact with current disease and 
positive reaction (more than 20 mm induration) to the 5 tu-
berculin unit (TU) purified protein derivative (PPD).
Following precautions were taken while performing the 
ADA and other routine tests on the fluids: (1) Fluids were 
collected in sterile containers; (2) Detailed gross examina-
tion which included volume, color, turbidity, any flakes etc. 
was noted; (3) Microscopic examination of the fluid was 
done for total and differential leukocyte count and also for 
 
Type of Fluid
 
Negative
 
Positive
 
Serum/plasma/Pleural/
Ascitic/synovial Fluids 
 
40 or < 40
 
> 40
CSF 10 or < 10 > 10
Table 1. Reference Values of ADA in Various Body 
Fluids (U/L)
 
Type of Disease
 
Aspirated Fluid 
 
Etiology;  
According to Set Criteria
 
Number of Cases
 
1. Pulmonary
 
Pleural (n = 72)
 
Tuberculous 
 
42
Non tuberculous 30
2. Extra-Pulmonary Ascitic/Peritoneal  
(n = 108) 
Tuberculous  36
Non tuberculous 72
CSF (n = 120)  Tuberculous  54
Non tuberculous 66
Synovial (n = 30) Tuberculous  21
Non tuberculous 09
Total 330
Table 2. Table Showing Distribution of Cases According to the Initial Set Criteria
   121                                   122J Clin Med Res  •  2010;2(3):121-126    Adenosine Deaminase in Serosal Effusion
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press™   |   www.jocmr.org
any other abnormal cell; (4) Fluid was centrifuged, slide 
prepared from the residue, stained by Z - N staining and 
examined for AFB microscopically; (5) ADA test was 
done by Guisti and Galanti method [8] on the same day, 
the fluid was received. If a delay in performing the test 
was anticipated, the fluid was kept in the refrigerator at 
2 - 4 oC after adding glycerol to it, to avoid decrease in 
ADA level with the lapse of time at ambient tempera-
ture.
In case of readings beyond the linearity of the assay 
system, the test was repeated with appropriate dilutions 
of the samples and the result was calculated considering 
the dilution factor. In case of turbid effusions the fluids 
were centrifuged and the test was performed from the 
clear supernatant. And if the fluid was still found to be 
turbid, it was excluded from the study. 
Reference values, as follows, were taken as per the 
recommendations of Microxpress, a division of Tulip 
Diagnostics (P) Ltd. India, of which chemicals and re-
agents were used. ADA levels above 40 U/L were taken as 
positive in samples from pleural, ascitic or synovial fluid 
while ADA levels above 10 U/L were taken as positive in 
CSF (Table 1).
 
Results
Out of 330 aspirated samples, 72 were pulmonary (Pleural) 
and 258 were extra-pulmonary serosal effusions. Amongst 
extra-pulmonary, 108 were peritoneal (Ascitic), 120 were 
cerebrospinal and 30 were synovial fluids. These samples 
were divided according to the criteria set for tuberculosis: 
42 samples were tubercular while 30 were non-tuberculous 
amongst pulmonary disease and amongst extra-pulmonary; 
36 samples were tubercular while 72 were non-tubercular 
in abdominal disease; 54 samples were tubercular while 66 
were non-tubercular in cerebrospinal disease; and 21 sam-
ples were tubercular while 9 were non-tubercular in muscu-
Table 3. Table Showing ADA and AFB Positivity in Tubercular Group
 
Type of Tubercular 
Disease
 
Aspirated Fluid 
 
Etiology; No. of Tubercular 
Cases According to Set Criteria
 
AFB Positive 
Cases
 
Pulmonary (n = 42)
 
Pleural (n = 72)
 
42
 
14
Extra-Pulmonary (n = 111) Ascitic/Peritoneal (n = 108) 36 09
CSF (n = 120)  54 nil
Synovial (n = 30) 21 nil
Total 153 23
 
Type of Fluid
 
Cut Off
 
Range U/L
 
Median
 
Pleural
 
> 40
 
40.4 - 136
 
88
≤ 40 4.8 - 38 21.5
Ascitic/Peritoneal > 40 48 - 180 110
≤ 40 3.3 - 40 16
Synovial > 40 46 - 156 88
≤ 40 25 - 32.6 27.2
CSF > 10 10.2 - 110 24
≤ 10 2 - 10 6.4
Table 4. Table Showing Range of ADA With Median Corresponding to Etiology
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loskeletal disease (Table 2). 
Only  14/42  (33.34%)  amongst  pulmonary  tubercular 
disease and 9/36 (25%) amongst peritoneal tubercular dis-
ease were confirmed by direct evidence of AFB while none 
in synovial fluid and CSF showed the evidence of AFB posi-
tivity. In the present study, only 23/153 (15.03%) patients 
could be conformed by evidence of AFB (Table 3).
ADA levels in tubercular pleural fluid ranged between 
40.4 and 136 with a median value of 88 while in non-tuber-
cular pleural effusions it ranged between 4.8 and 38 with 
a median value of 21.5. ADA levels in tubercular ascitis 
ranged between 48 and 180 with a median level of 110, and 
in non- tubercular ascitis it ranged between 3.3 and 40 with a 
median value of 16. ADA levels in tubercular joint effusions 
ranged between 46 and 156 with a median level of 88, and 
in non- tubercular joint effusions it ranged between 25 and 
32.6 with a median value of 27.2. ADA levels in tubercular 
CSF ranged between 10.2 and 110 with median value of 24, 
and  in non-tubercular CSF value was found to be between 2 
and 10 with a median value of 6.4 (Table 4).
In the present study amongst pulmonary tubercular dis-
ease samples, 39/42 had ADA levels above 40 U/L, while 
27/30 of non-tuberculous pleural fluid had ADA levels no 
more than 40 U/L. In extra-pulmonary disease, tubercular 
samples 33/36 of ascitic fluid, 18/21 of synovial fluid and 
48/54 of CSF had ADA levels above the cutoff, while in 
non-tubercular samples 72/72 of ascitic fluid, 6/9 of synovial 
fluid and 63/66 of CSF had values below the cutoff (Table 5).     
In extra-pulmonary disease, tubercular samples 99/111 
had ADA levels above the cutoff, while in non-tubercular 
samples 141/147 had below the cutoff level (Table 5). Sen-
sitivity, specificity, positive predictive values and negative 
predictive values were calculated using standard formulae. 
In  our  study,  in  cases  with  pleuropulmonary  disease 
sensitivity was found to be 92.80%, specificity was 90.00%, 
positive  predictive  value  92.86%  and  negative  predictive 
value  90.00%.  In  cases  of  extra-pulmonary  disease  with 
the involvement of peritoneum, sensitivity was found to be 
Table 5. Sensitivity, Specificity, Negative and Positive Predictive Values of ADA Estimation in Different Groups
 
Type of 
Disease
 
Aspirated 
Fluid
 
Etiology 
According to 
Set Criteria
 
Cut Off 
Value of 
ADA
 
Number 
of True 
Positive/
Negative 
Cases 
 
Sensitivity 
%
 
Specificity 
%
 
Positive 
Predictive 
Value %
 
Negative 
Predictive 
Value %
 
Pulmonary   
(n = 72)
 
Pleural  
(n = 72)
 
Tuberculous 
(n = 42) 
 
> 40
 
39
 
92.80
 
90.00
 
92.86
 
90.00
Non-tuberculous 
(n = 30)
≤ 40 27
Extra-
Pulmonary 
(n = 258)
Over all 
includes;
Tuberculous 
(n = 111)  
> 40/10 99 94.29 92.16 89.00 95.92
Non-tuberculous 
(n = 147)
≤ 40/10 141
Ascitic 
(n = 108)
Tuberculous 
(n = 36)  
> 40 33 100 96 91.67 100.00
Non-tuberculous 
(n = 72)
≤ 40 72
Synovial 
(n = 30)
Tuberculous 
(n = 21)  
> 40 18 85.71 66.67 85.71 66.67
Non-tuberculous 
(n = 09)
≤ 40 06
CSF  
(n = 120)
Tuberculous 
(n = 54)  
> 10 48 84.12 91.30 88.89 95.46
Non-tuberculous 
(n = 66)
≤ 10 63
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100.00%, specificity was 96.00%, positive predictive value 
91.67% and negative predictive value 100.00%; in cases of 
musculoskeletal disease, sensitivity was found to be 85.71%, 
specificity was 66.67%, positive predictive value 85.71% 
and  negative  predictive  value  66.67%;  while  in  cases  of 
meningeal involvement, sensitivity was found to be 84.12%, 
specificity was 91.30%, positive predictive value 88.89% 
and negative predictive value 95.46% (Table 5).
In extra-pulmonary disease, the overall sensitivity was 
found  to  be  94.29%,  specificity  was  92.16%,  and  posi-
tive predictive value 89.00% and negative predictive value 
95.92% (Table 5).
Discussion
  
Demonstration of AFB, culture, CT and MRI scan etc. are 
the various means to confirm the etiology of tuberculosis but 
visualization of AFB in direct smears or in cultures is usu-
ally difficult [9] and in most cases negative. Newer methods 
such as those involving the amplification of bacterial DNA 
by the PCR and comparable systems, are not available for 
widespread use in the developing countries. Routine labora-
tory findings may not be helpful to differentiate tuberculous 
etiology from other causes. 
Cell-mediated response is the predominant form of im-
mune response to tuberculous infection, while both cell-me-
diated and humoral immune responses are elicited by most 
non-tuberculous infections in human body. Thus ADA activ-
ity, a marker of T-cell activation and cell-mediated immune 
response can help differentiate tubercular etiology from non-
tubercular.
Piras et al were first to report high ADA in tubercular 
pleural effusion [10]. Subsequently several workers explored 
its efficacy in the diagnosis of tuberculosis [11] and deter-
mined that pleural fluid ADA level less than 40 U/L virtually 
excludes the diagnosis of tuberculosis [3]. Meta-analysis of 
studies conducted between 1966 and 1999 concluded that the 
test performance was reasonably good [12] (sensitivity range 
47.1 - 100%, and specificity 0 - 100%) in diagnosing tuber-
culosis etiology in pleural effusion. 
Ocana et al in 1983 [11] and Valdes et al in 1993 [13] 
and 1996 [14, 15] reported 100% sensitivity and specific-
ity, positive predictive value and negative predictive value in 
larger sample size studies. 
Perez [16] reported the sensitivity and specificity for 
ADA to be 77 - 100% (average, 93.3%) and 81 - 97% (Aver-
age, 91.3%) respectively on summarizing eleven studies, and 
Chen et al [17] reported the sensitivity and specificity for 
ADA as 79 - 100% (average, 88.6%) and 80.5 - 96% (aver-
age, 85.4%) respectively on summarizing the results of eight 
studies.
In 2007, a systematic review of ADA by the NGS Health 
Technology Assessment Programme concluded that there is 
no evidence to support the use of ADA tests for the diagnosis 
of pulmonary TB. However, there is considerable evidence 
to support their use in pleural fluid samples for diagnosis of 
pleural TB, where sensitivity was very high, and to a slightly 
lesser extent for TB meningitis. In both pleural TB and TB 
meningitis, ADA tests had higher sensitivity than any other 
tests [18]. 
CSF-ADA estimation was reported to be useful in di-
agnosing TBM and can differentiate TBM from other neu-
rological disorders [19]. CSF-ADA estimation is a useful 
method to differentiate TBM from aseptic meningitis [5]. 
Other researchers have also observed the usefulness of ADA 
activity in the diagnosis of tubercular disease [20, 21].  
Other causes of increase in ADA activity include bac-
terial infections, rheumatic disease and lymphoproliferative 
disorders. This article reviews ADA estimation as an effec-
tive diagnostic criterion for tuberculous and non-tuberculous 
disease in pleural, ascitic, synovial fluids and CSF.
In our study, in extra-pulmonary disease with the in-
volvement  of  peritoneum,  sensitivity  was  found  to  be 
100.00%,  specificity  96.00%,  positive  predictive  value 
91.67%  and  negative  predictive  value  100.00%;  in  cases 
of involvement of musculo-skeletal disease, sensitivity was 
found to be 85.71%, specificity 66.67%, positive predictive 
value 85.71% and negative predictive value 66.67%; while 
in cases of meningeal involvement, sensitivity was found 
to be 84.12%, specificity 91.30%, positive predictive value 
88.89 % and negative predictive value 95.46%.
In extra-pulmonary disease, our overall sensitivity was 
found to be 94.29%, specificity 92.16%, positive predictive 
value 89.00% and negative predictive value 95.92%; and 
in pulmonary disease, sensitivity was found to be 92.80%, 
specificity 90.00%, positive predictive value 92.86 % and 
negative predictive value 90.00%. 
We have observed a statistically significant difference in 
ADA levels of tubercular and non-tuberculous etiology (p < 
0.01). Results of our study indicated that ADA levels in the 
aspirated fluid are of considerable value in differentiating be-
tween tubercular and non-tubercular disease with fairly high 
accuracy and sensitivity at the taken cutoff. 
In TB endemic countries like India, patients with raised 
ADA levels could be a signal for tuberculosis where AFB 
positivity is low. This may help in early diagnosis and insti-
tution of ATT, thus can significantly alter not only the spread 
but also the progress and prognosis of TB in our country. 
Our study is a unique study debating the significance of ADA 
estimation in diverse form of extra-pulmonary TB including 
musculoskeletal tuberculosis.
ADA  estimation  can  also  be  of  considerable  help  in 
western countries where other causes of lymphocyte rich 
effusions should be considered like coccidiodomycosis and 
histoplasmosis. ADA levels, in these cases, are found to be 
below the cutoff value and thus save the patient from unnec-
essary anti-tubercular treatment. 
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It can be concluded that ADA estimation is not only ef-
fective but also simple, inexpensive, quick to perform test; 
it can be used as an alternative to biopsy/culture and also 
as a guide for further sophisticated investigations. This test 
may find a place as a routine investigation in the coming 
days for early detection of tuberculosis where other means 
are expensive.
In conclusion, ADA estimation is not only a fairly sen-
sitive and specific test (more than 90%), helpful in differ-
entiating  tubercular  from  non-tubercular  etiology  both  in 
pulmonary and extra-pulmonary disease, but is also simple, 
inexpensive and rapid. For this reason this test may help in 
early diagnosis, improve the prognosis and reduce spread of 
disease and sequlae. 
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